Xuebijing enhances neuroprotective effects of ulinastatin on transient cerebral ischemia via Nrf2-are signal pathways in the hippocampus

H X. Hu, M Q. Zhu, Y C. Sun, C. Ma, X. Wang, X L. Liu

Article ID: 5249
Vol 32, Issue 5, 2018
DOI: https://doi.org/10.54517/jbrha5249
Received: 8 November 2018; Accepted: 8 November 2018; Available online: 8 November 2018; Issue release: 8 November 2018

Abstract

Prior studies have demonstrated that ulinastatin (UTI) plays a beneficial role in regulating cerebral ischemic injury evoked by cardiac arrest (CA). It is noteworthy to find interventions that can enhance effects of this drug and thereby increase its clinical application. Xuebijing (XBJ) is comprised of extracts from Chinese herbs and has been widely used in China as an anti-endotoxicity drug for the treatment of sepsis and ischemic disorders associated with multiple organ dysfunction syndrome. Thus, in this study we examined the effects of a combination of UTI and XBJ to improve neural injury in the process of neurological functions after transient cerebral ischemia. Our results show that CA impaired Nrf2- antioxidant response element (Nrf2-ARE) and superoxide dismutase (SOD) in the hippocampus CA1 region. This process further amplified products of oxidative stress, namely 8-isoprostaglandin F2α (8-iso PGF2α) and 8-hydroxy-2-deoxyguanosine (8-OHdG). A lower dose of UTI failed to restore Nrf2-ARE and attenuate 8-iso PGF2α and 8-OHdG SOD following CA; however, systemic administration of XBJ amplified the effects of this dose of UTI on antioxidative signal pathway of the hippocampus. Overall, the results of this study have implications for the enhanced neuroprotective role played by a combination of XBJ and UTI in improving neural injury observed in transient cerebral ischemia; and Nrf2-ARE signal is a part of key mechanisms that are involved in neuroprotective effects of XBJ and UTI.


Keywords

Xuebijing;ulinastatin;oxidative stress;cardiopulmonary resuscitation;cardiac arrest;cerebral ischemia


References

Supporting Agencies



Copyright (c) 2018 H X. Hu, M Q. Zhu, Y C. Sun, C. Ma, X. Wang, X L. Liu




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).